ACTIVE IDIOPATHIC INFLAMMATORY MYOPATHY

Clinical trials for ACTIVE IDIOPATHIC INFLAMMATORY MYOPATHY explained in plain language.

Never miss a new study

Get alerted when new ACTIVE IDIOPATHIC INFLAMMATORY MYOPATHY trials appear

Sign up with your email to follow new studies for ACTIVE IDIOPATHIC INFLAMMATORY MYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Four-Year trial tests promising drug for debilitating muscle diseases

Disease control ENROLLING_BY_INVITATION

This study follows up on previous participants to check the long-term safety and effectiveness of efgartigimod injections for inflammatory muscle diseases like dermatomyositis and polymyositis. About 240 adults who completed an earlier trial will receive the treatment for up to 5…

Matched conditions: ACTIVE IDIOPATHIC INFLAMMATORY MYOPATHY

Phase: PHASE3 • Sponsor: argenx • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

ACTIVE IDIOPATHIC INFLAMMATORY MYOPATHY

Get alerted when new ACTIVE IDIOPATHIC INFLAMMATORY MYOPATHY trials appear

Four-Year trial tests promising drug for debilitating muscle diseases